UNIVERSITA DEGLI STUDI DI CAMERINO

Their core work

UNICAM is an Italian university with strong research capabilities in advanced medical imaging, nanomaterials, and biomaterials for healthcare applications. Their teams develop fluorine-19 MRI techniques and nanoparticle-based diagnostic tools, with a growing focus on non-surgical cancer monitoring and chronic pain treatment. They also contribute to quantum sensing technologies and optomechanical systems, maintaining a broad but increasingly health-oriented research portfolio.

What they specialise in

How they've shifted over time

In the early period (2014–2018), UNICAM's portfolio was diverse and exploratory — spanning bioinformatics, optomechanics, health tourism, aging, and well-being research with no single dominant theme. From 2019 onward, the university sharpened its focus dramatically toward medical imaging (especially 19F MRI), nanomaterials for diagnostics and therapy, and non-surgical cancer monitoring. This shift reflects a deliberate consolidation around translational health research, particularly where advanced materials meet clinical imaging.

UNICAM is converging on nanoparticle-based medical imaging and diagnostics, making them a strong partner for projects needing advanced MRI techniques or non-invasive cancer monitoring tools.

How they like to work

UNICAM operates predominantly as a consortium partner (13 of 16 projects), contributing specialist expertise rather than leading large consortia. With 123 unique partners across 26 countries, they maintain a wide and non-exclusive network, suggesting openness to new collaborations. Their three coordinated projects are smaller-scale (MSCA-RISE and ERC-PoC), indicating they are comfortable leading focused research exchanges but prefer to contribute as experts in larger initiatives.

UNICAM has built a broad European network of 123 unique partners across 26 countries, reflecting heavy participation in MSCA mobility schemes that naturally connect institutions across borders. Their network is wide rather than deep, typical of a university that brings niche expertise to many different consortia.

What sets them apart

UNICAM brings a rare combination of advanced 19F MRI expertise and nanomaterials development under one roof, supported by multiple coordinated and partner projects in this exact intersection. For a mid-sized Italian university, their 26-country network is unusually extensive, built through consistent MSCA participation. They are particularly well-suited for consortia needing a partner who can bridge materials science and medical imaging without the overhead of a large research institution.

Highlights from their portfolio

• NOVA-MRI
  UNICAM's flagship coordinated project developing novel 19F MRI applications — their clearest statement of core expertise in fluorine-based imaging.
• HOT
  Largest single EC contribution (EUR 561,928) in hybrid optomechanical technologies, showing UNICAM can attract significant funding in physics-based research.
• CAST
  Part of a sustained research line (with PRISAR2) on active cancer monitoring as an alternative to surgery — directly translational and clinically relevant.